Elf Bar’s Parent Company Withdraws From California Market After Settlement With NJOY
Oct 18, 2025
Leave a message
Settlement Ends Market Battle
On October 11, 2025, Law360 reported that iMiracle (HK) Ltd. and Shenzhen iMiracle Technology Co., Ltd., the Chinese parent companies of Elf Bar, reached a settlement with NJOY LLC, a subsidiary of Altria Group. As part of the agreement, iMiracle will completely withdraw from California's flavored e-cigarette market, and the court will issue a permanent injunction to enforce the ban.
Permanent Ban Seals Elf Bar's Fate
On October 9, both companies jointly filed a motion in the U.S. District Court for the Southern District of California, requesting a judge to approve a permanent injunction preventing them from selling any products that violate the state's flavored tobacco ban. Given Elf Bar's strong position in Western markets, losing California-one of the biggest vaping regions-marks a serious commercial blow. Any future violations could be considered contempt of court.
NJOY's Legal Advantage
While Elf Bar exits, NJOY emerges as the clear winner. Its strength lies in compliance: NJOY's Ace device is the only FDA-authorized pod-based e-cigarette, with even its menthol variant approved in June 2024. With Elf Bar out, NJOY stands to capture the vacated California market share, highlighting that regulatory approval is the ultimate competitive weapon.
The New Regulatory Era
The FDA has rejected over 1 million flavored e-cigarette applications, reinforcing that only scientifically reviewed products will survive. The Elf Bar case sends a clear message: compliance is not optional-it's survival.
Q&A (Legal/Compliance Focus)
Q1: What did Elf Bar's parent company agree to in the settlement?
A1: To permanently withdraw from California's flavored e-cigarette market.
Q2: Which company filed the motion with NJOY?
A2: iMiracle (HK) Ltd. and Shenzhen iMiracle Technology Co., Ltd.
Q3: Why is California important to Elf Bar?
A3: It's one of the largest e-cigarette markets in the U.S., crucial to sales.
Q4: What gives NJOY a regulatory advantage?
A4: Its Ace device is the only FDA-approved pod e-cigarette, including menthol flavor.
Q5: What broader lesson does the case highlight?
A5: Compliance and FDA authorization are key to long-term survival.
Send Inquiry

